Obesity-associated inflammation, that initially affects adipose tissue and liver, plays a key role in this phenomenon as it inhibits several insulin-associated signalling pathways, such as insulin receptor substrate 1 (IRS-1) [65], and it increases plasma-free fatty acid (FFA), thus stimulating lipolysis [66]. Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.